Fighting HIV with stem cell therapy: One step closer to human trials?

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 10, 2012, Pages 1071-1073

  Anderson, Joseph S ^a   Bauer, Gerhard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anti HIV genes; gene therapy; HIV cure; stem cells

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; COMPLEMENTARY RNA; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LENTIVIRUS VECTOR; PROTEIN DERIVATIVE; RETROVIRUS VECTOR; RIBOZYME; RNA DERIVATIVE; TRANSDOMINANT NEGATIVE PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CCR5 GENE; CELLULAR IMMUNITY; CLINICAL EFFECTIVENESS; DISEASE COURSE; DRUG MEGADOSE; GENE EXPRESSION; GENE THERAPY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; INFECTION CONTROL; LYMPHOMA; MORTALITY; NONHUMAN; PUBLIC HEALTH PROBLEM; REVIEW; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION; VIRUS RESISTANCE;

CLINICAL TRIALS AS TOPIC; GENETIC THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; HUMANS; VIRAL LOAD; VIRUS REPLICATION;

EID: 84870606218     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.105     Document Type: Review

References (12)

1. Baltimore D. Gene therapy. Intracellular immunization. Nature 335(6189), 395-396 (1988).
2. Bauer G, Selander D, Engel B et al. Gene therapy for pediatric AIDS. Ann. N. Y. Acad. Sci. 918, 318-329 (2000).
3. Bauer G, Valdez P, Kearns K et al. Inhibition of human immunodefciency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes. Blood 89(7), 2259-2267 (1997).
4. Verma S, Woffendin C, Bahner I et al. Gene transfer into human umbilical cord blood-derived CD34+ cells by particle-mediated gene transfer. Gene Ther. 5(5), 692-699 (1998).
5. Kohn DB, Bauer G, Rice CR et al. A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34+ cells from the bone marrow of human immunodefciency virus-1-infected children. Blood 94(1), 368-371 (1999).
6. Podsakoff GM, Engel BC, Carbonaro DA et al. Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34+ cells. Mol. Ther. 12(1), 77-86 (2005).
7. Kohn DB, Sadelain M, Glorioso JC. Occurrence of leukaemia following gene therapy of X-linked SCID. Nat. Rev. Cancer 3(7), 477-488 (2003).
8. Liu R, Paxton WA, Choe S et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86(3), 367-377 (1996).
9. Allers K, Hütter G, Hofmann J et al. Evidence for the cure of HIV infection by CCR5D32/D32 stem cell transplantation. Blood 117(10), 2791-2799 (2011).
10. DiGiusto DL, Krishnan A, Li L et al. RNA-based gene therapy for HIV with lentiviral vector-modifed CD34+ cells in patients undergoing transplantation for AIDS-related lymphoma. Sci. Transl. Med. 2(36), 36ra43 (2010).
11. Anderson JS, Walker J, Nolta JA, Bauer G. Specifc transduction of HIV-susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunization. J. Acquir. Immune Defc. Syndr. 52(2), 152-161 (2009).
12. Walker JE, Chen RX, McGee J et al. Generation of an HIV-1-resistant immune system with CD34+ hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. J. Virol. 86(10), 5719-5729 (2012).